{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:05:46Z","timestamp":1761861946811,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.medcli.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T07:27:38Z","timestamp":1671175658000},"page":"213-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Follow-up regimens for carriers of hereditary transthyretin variants"],"prefix":"10.1016","volume":"160","author":[{"given":"In\u00e9s Asunci\u00f3n","family":"Losada-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Kapetanovic-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Sevilla-Mantec\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mu\u00f1oz-Beamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2022.10.002_bib0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/TCRM.S219979","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis (Hattr) polyneuropathy: current perspectives on improving patient care","volume":"16","author":"Luigetti","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.medcli.2022.10.002_bib0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/TCRM.S185677","article-title":"Diagnosis and screening of patients with hereditary transthyretin amyloidosis (Hattr): current strategies and guidelines","volume":"16","author":"Benson","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.medcli.2022.10.002_bib0155","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00415-017-8708-4","article-title":"Transthyretin familial amyloid polyneuropathy: an update","volume":"265","author":"Plante-Bordeneuve","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0160","first-page":"50","article-title":"Multidisciplinary approach in the management of hATTR","author":"Losada","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.medcli.2022.10.002_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2022.10.002_bib0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2022.10.002_bib0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2022.10.002_bib0180","doi-asserted-by":"crossref","first-page":"116813","DOI":"10.1016\/j.jns.2020.116813","article-title":"Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies","volume":"414","author":"Ueda","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.medcli.2022.10.002_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","article-title":"Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations","volume":"26","author":"Concei\u00e7\u00e3o","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.medcli.2022.10.002_bib0190","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/WCO.0000000000000290","article-title":"Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis","volume":"29","author":"Obici","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0195","first-page":"56","article-title":"Assessing mNIS+7 Ionis and international neurologists\u2019 proficiency in a familial amyloidotic polyneuropathy trial","author":"Dyck","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.medcli.2022.10.002_bib0200","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/ene.15176","article-title":"Changes in nerve conduction studies predate clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis","volume":"29","author":"Castro","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/MCP.0000000000000413","article-title":"Small fiber neuropathy: a disabling and underrecognized syndrome","volume":"23","author":"Voortman","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.medcli.2022.10.002_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neucli.2015.09.012","article-title":"Diagnosis of small fiber neuropathy: a comparative study of five neurophysiological tests","volume":"45","author":"Lefaucheur","year":"2015","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.medcli.2022.10.002_bib0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10286-018-0514-2","article-title":"Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)","volume":"29","author":"Gonzalez-Duarte","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.medcli.2022.10.002_bib0220","first-page":"222","article-title":"Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)","author":"Gonz\u00e1lez-Duarte","year":"2019","journal-title":"Auton Neurosci Basic Clin"},{"key":"10.1016\/j.medcli.2022.10.002_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10286-019-00623-x","article-title":"Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management","volume":"29","author":"Palma","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.medcli.2022.10.002_bib0230","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clinph.2020.11.024","article-title":"Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology","volume":"132","author":"Cheshire","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0235","first-page":"127","article-title":"The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy","author":"Castro","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JND-200490","article-title":"Current view of diagnosing small fiber neuropathy","volume":"8","author":"Raasing","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.medcli.2022.10.002_bib0245","first-page":"19","article-title":"Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy","author":"Vinik","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.medcli.2022.10.002_bib0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13506129.2019.1627312","article-title":"Assessment of patients with hereditary transthyretin amyloidosis \u2013 understanding the impact of management and disease progression","volume":"26","author":"Concei\u00e7\u00e3o","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.medcli.2022.10.002_bib0255","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2022.10.002_bib0260","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrneurol.2012.97","article-title":"Small-fibre neuropathies-advances in diagnosis, pathophysiology and management","volume":"8","author":"Hoeijmakers","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0265","first-page":"134","article-title":"Potential role of in vivo confocal microscopy for imaging corneal nerves in transthyretin familial amyloid polyneuropathy","author":"Rousseau","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.medcli.2022.10.002_bib0270","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","author":"Adams","year":"2020","journal-title":"J Neurol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:55:54Z","timestamp":1758419754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775322005310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0025775322005310"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2022.10.002","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follow-up regimens for carriers of hereditary transthyretin variants","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}